nj-department-of-human-services-agenda-2024-04-17_e97.pdf
Genentech's Evrysdi Included in SMA Protocol Update
Trusted by teams at
Description
The Board recommended an addendum to the Spinal Muscular Atrophy (SMA) protocol, expanding Medicaid coverage of Evrysdi, manufactured by Genentech Inc.
Contract Details
Vendor
GENENTECH INC
Agency
NJ Department of Human Services, NJ
Contract Type
SUPPLIES
Document Date
April 17, 2024
Renewal Info
Protocol reviewed and updated periodically; new addendum as of April 2024.
More from GENENTECH INC
Related Contracts
City of South San Francisco Regular Meeting Agenda 2026-05-27
PENDINGtown-of-holly-springs-economic-development-agreement_ac5.pdf
PENDINGState of Alaska Disciplinary Action Report Oct-Dec 2024
APPROVEDCity of South San Francisco Special Meeting Agenda May 2024
DISCUSSSEDcentral-michigan-university-meeting-minutes-2023-09-28_611.pdf
AWARDEDMore from NJ Department of Human Services
New Jersey Drug Utilization Review Board Agenda April 2026
nj-department-of-human-services-drug-utilization-review-board-agenda-october-2025_148.pdf
nj-dhs-durb-agenda-drug-protocol-updates-utilization-trends-jul-16-2025_a3a.pdf
nj-dept-of-human-services-durb-agenda-drug-utilization-protocol-reviews-july-16-2025_b3a.pdf
nj-department-of-human-services-agenda-2025-04-23_0b7.pdf
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.